Russell Investments Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-185
Closed -$3.04K 4156
2025
Q2
$3.04K Buy
185
+147
+387% +$2.54K ﹤0.01% 3533
2025
Q1
$699 Sell
38
-84
-69% -$2.4K ﹤0.01% 3636
2024
Q4
$4.53K Buy
122
+7
+6% +$268 ﹤0.01% 3307
2024
Q3
$3.68K Sell
115
-137
-54% -$7.6K ﹤0.01% 3281
2024
Q2
$20.7K Buy
252
+194
+334% +$21K ﹤0.01% 2932
2024
Q1
$8.4K Buy
+58
New +$4.9K ﹤0.01% 2870
2023
Q4
Sell
-77
Closed -$12.8K 3221
2023
Q3
$12.8K Sell
77
-1,736
-96% -$226K ﹤0.01% 2955
2023
Q2
$115K Hold
1,813
﹤0.01% 2582
2023
Q1
$61.6K Sell
1,813
-47
-3% -$2.46K ﹤0.01% 2683
2022
Q4
$107K Buy
+1,860
New +$115K ﹤0.01% 2659
2022
Q3
Sell
-5,143
Closed -$1.15M 2912
2022
Q2
$1.15M Sell
5,143
-1,475
-22% -$494K ﹤0.01% 1896
2022
Q1
$3.64M Sell
6,618
-462
-7% -$279K 0.01% 1323
2021
Q4
$4.68M Buy
7,080
+3,510
+98% +$2.68M 0.01% 1287
2021
Q3
$3M Sell
3,570
-1,229
-26% -$1.25M 0.01% 1579
2021
Q2
$6.09M Buy
4,799
+158
+3% +$178K 0.01% 1220
2021
Q1
$5.09M Sell
4,641
-2,424
-34% -$3.2M 0.01% 1364
2020
Q4
$10.1M Buy
7,065
+433
+7% +$462K 0.02% 846
2020
Q3
$4.68M Buy
6,632
+32
+0.5% +$23.3K 0.01% 1171
2020
Q2
$4.62M Buy
6,600
+1,723
+35% +$995K 0.01% 1144
2020
Q1
$1.71M Buy
4,877
+195
+4% +$138K ﹤0.01% 1549
2019
Q4
$2.94M Buy
4,682
+2,665
+132% +$1.3M 0.01% 1514
2019
Q3
$675K Buy
2,017
+347
+21% +$111K ﹤0.01% 2188
2019
Q2
$432K Sell
1,670
-6,069
-78% -$1.22M ﹤0.01% 2302
2019
Q1
$1.28M Buy
7,739
+966
+14% +$157K ﹤0.01% 1936
2018
Q4
$734K Buy
6,773
+1,113
+20% +$188K ﹤0.01% 2144
2018
Q3
$1.42M Buy
5,660
+809
+17% +$174K ﹤0.01% 1931
2018
Q2
$1.06M Buy
4,851
+2,152
+80% +$398K ﹤0.01% 2096
2018
Q1
$395K Buy
+2,699
New +$457K ﹤0.01% 2532

Other funds holding CDLX

Russell Investments Group's CDLX Position: Q3 2025 in Review

Russell Investments Group sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 185 shares — an estimated $3.04K sold.

Russell Investments Group first reported a position in CDLX in Q1 2018 and held it in 28 quarters. The position peaked at $10.1M in Q4 2020. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Russell Investments Group reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Russell Investments Group sold 185 Cardlytics shares in Q3 2025, an estimated $3.04K.
  • Russell Investments Group first reported a position in Cardlytics in Q1 2018 and held it in 28 quarters.
  • Russell Investments Group's Cardlytics position peaked at $10.1M in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.